In silico discovery of novel Retinoic Acid Receptor agonist structures

BACKGROUND: Several Retinoic Acid Receptors (RAR) agonists have therapeutic activity against a variety of cancer types; however, unacceptable toxicity profiles have hindered the development of drugs. RAR agonists presenting novel structural and chemical features could therefore open new avenues for...

Descripción completa

Detalles Bibliográficos
Autores principales: Schapira, Matthieu, Raaka, Bruce M, Samuels, Herbert H, Abagyan, Ruben
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2001
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC32304/
https://www.ncbi.nlm.nih.gov/pubmed/11405897
http://dx.doi.org/10.1186/1472-6807-1-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC32304/
https://www.ncbi.nlm.nih.gov/pubmed/11405897
http://dx.doi.org/10.1186/1472-6807-1-1

Ejemplares similares